Discussant panel

6 More presentations in this session

Treatment uptake in the era of quadruple pharmacotherapy for heart failure with reduced ejection fraction: from prescriptions to patient adherence and persistence

Doctor F. Lindberg (Stockholm, SE)

Slides Video

Improvements in medical therapy and prognosis for patients with HFrEF following the 2021 ESC HF Guidelines: a nationwide registry study

Doctor K. Berge (Nordbyhagen, NO)

Slides Video

Contemporary patient characterization and implementation of medical therapy for heart failure across the ejection fraction spectrum: the OPTIPHARM-HF registry

Doctor R. Inciardi (Brescia, IT)

Slides Video

Timing of cardiac resynchronization therapy after optimal medical therapy in patients with heart failure: temporal trends, predictors and association with outcomes

Doctor A. Villaschi (Milan, IT)

Slides Video

Cardiac resynchronization therapy in heart failure: a target trial emulation study

Doctor C. Basile (Stockholm, SE)

Slides Video